FORENSIC TOXICOLOGY - Bio Medical Forensics

Compliance of Individuals Prescribed
Dexedrine® Through Determination of
Amphetamine Isomer Ratios in Oral Fluid
Detection of Ketamine in Urine of
Nonhuman Primates After a Single Dose
Using Microplate Enzyme-Linked
ImmunoSorbent Assay (ELISA)
2,5-Dimethoxy-4-npropylthiophenethylamine
(2C-T-7) Dose
Response Relationship in the Rat
Use of MDA (the “Love Drug”) and
Methamphetamine in Toronto by
Unsuspecting Users of Ecstasy (MDMA)
Postmortem Morphine Concentrations –
Are They Meaningful?
A Review of Succinylmonocholine
Concentrations in Body Fluids and Tissues
Analyzed by LC-MS/MS
Postmortem Ropivacaine (Naropin)
Concentrations
Gail A. Cooper, PhD*, Cozart Bioscience, Ltd, 45 Milton
Park, Abingdon, Oxfordshire OX14 4RU, United Kingdom;
Frank T. Peters, PhD and Hans H. Maurer, PhD,
Department of Experimental and Clinical Toxicology,
University of Saarland, Homburg D-66421, Germany;
Chris Hand, PhD, Cozart Bioscience, Ltd, 45 Milton Park,
Abingdon, Oxfordshire OX14 4RU, United Kingdom
Donna E. Webster, BS*, Matthew P. Juhascik, MS, Bindu
K. Saini, BA, and Piotr Adamowicz, MS, University of
Illinois at Chicago, Department of Biopharmaceutical
Sciences (M/C865), 833 South Wood Street, Chicago, IL
60612; Christine M. Moore, PhD, United States Drug
Testing Laboratories, Inc., 1700 South Mount Prospect
Road, Des Plaines, IL 60018; R. Francis Schlemmer, PhD,
University of Illinois at Chicago, Department of
Biopharmaceutical Sciences (M/C865), 833 South Wood
Street, Chicago, IL 60612; Adam Negrusz, PhD, DSc,
University of Illinois at Chicago, Department of
Biopharmaceutical Sciences (M/C865), 833 South Wood
Street, Chicago, IL 60612
Byron D. Curtis, BS*, Office of Chief Medical Examiner,
901 North Stonewall, Oklahoma City, OK 73117; Philip M.
Kemp, PhD, H.D. Christensen, PhD, and Lester Reinke,
PhD, Department of Pharmaceutical Sciences, College of
Pharmacy, University of Oklahoma, PO Box 26901,
Oklahoma City, OK 73190
Kathryn S. Kalasinsky, PhD, Division of Forensic
Toxicology, Armed Forces Institute of Pathology,
Washington, DC 20306; John Hugel, BSc, Drug Analysis
Service, Health Canada, Toronto, Ontario M1P 4R7,
Canada; Stephen J. Kish, PhD*, Centre for Addiction and
Mental Health, Human Neurochemical Pathology Lab,
Toronto, Ontario M5T 1R8, Canada
Christena L. Langee, MD* and Bruce A. Goldberger, PhD,
University of Florida, Department of Pathology,
Immunology and Laboratory Medicine, PO Box 100275,
Gainesville, FL 32610-0275; Julia V. Martin, MD, District
Five Medical Examiner’s Office, 809 Pine Street,
Leesburg, FL 34748
Michael F. Rieders, PhD*, Kevin D. Ballard, MD, PhD,
Francis X. Diamond, Loan T. Nguyen, Eric F. Rieders,
PhD, and William E. Vickery, National Medical Services,
Inc., 3701 Welsh Road, Willow Grove, PA 19090; Fredric
Rieders, PhD, Fredric Rieders Family Renaissance
Foundation, 2300 Stratford Avenue, Willow Grove, PA
19090
Diana Garside, PhD*, Jeri D. Ropero-Miller, PhD, and
Ruth E. Winecker, PhD, Office of the Chief Medical
Examiner, 1001 Brinkhous-Bullitt Building, Chapel Hill,
NC 27599-7580; Donald R. Jason, MD, Wake Forest
University Baptist Medical Center, Department of
Pathology, Medical Center Boulevard, Winston-Salem, NC
27157-1072
Index 50
219
220
220
221
222
222
223